Cardiovascular diseases in people with diabetes mellitus in Spain according to the Primary Care Clinical Database (BDCAP) in 2017

Alarcón, Pedro Pujante; Torre, Edelmiro Luis Menéndez; Sánchez, Paula Morales; Escobedo, Raúl Rodríguez; Barreiro, Santiago Conde; Rojo-Martínez, Gemma; Delgado, Elías

doi:10.1016/j.medcle.2020.12.040

Cited by 3 publications

(1 citation statement)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A nivel de estado, existe la plataforma BDCAP (Base de Datos Clínicos de Atención Primaria) que recoge algunos datos de personas asignadas a atención primaria en el Sistema Nacional de Salud (SNS) de diferentes comunidades autónomas. Incluye datos relacionados con problemas de salud, interconsultas a especialidades hospitalarias, fármacos prescritos que han sido dispensados en las farmacias y visitas médicas 10,11 .…”

Section: ¿Qué Es El Sidiap?unclassified

Análisis Real World Data de algunas repercusiones de la pandemia de COVID-19 sobre el control metabólico de las personas con DM2

Franch-Nadal¹

2022

diabetpract

View full text Add to dashboard Cite

La actual pandemia de COVID-19 ha provocado importantes cambios tanto en los estilos de vida de los pacientes como en la forma de visitarlos. El uso de estándares de calidad asistencial nos proporciona información sobre estos cambios en el control metabólico. Durante el primer año después de la irrupción del COVID en Barcelona, se han registrado importantes descensos del porcentaje de pacientes con un buen control de la hemoglobina glicada (HbA1c) (en 19 puntos), de la tensión arterial (en 38 puntos), así como de la exploración de los pies (en 48 puntos) y del fondo de ojo (en 23 puntos). La tasa de mortalidad acumulada de los 12 últimos meses ha subido en 2,4 puntos (un 43 %). Las transformaciones asociadas al COVID-19 exigen un profundo planteamiento sobre cuál debería ser el modelo sanitario para la gestión de los pacientes crónicos en el siglo xxi.

show abstract

Section: ¿Qué Es El Sidiap?unclassified

Análisis Real World Data de algunas repercusiones de la pandemia de COVID-19 sobre el control metabólico de las personas con DM2

Franch-Nadal¹

2022

diabetpract

View full text Add to dashboard Cite

show abstract

Green liquid chromatographic method for simultaneous determination of metformin, linagliptin and rivaroxaban: Tablet manufacturing and application to in-vitro dissolution studies

Alam

Ali

Qayoom

et al. 2023

Microchemical Journal

View full text Add to dashboard Cite

Cardiac tissue engineering: an emerging approach to the treatment of heart failure

Rayat Pisheh,

Nojabaei,

Darvishi

et al. 2024

Front. Bioeng. Biotechnol.

View full text Add to dashboard Cite

Heart failure is a major health problem in which the heart is unable to pump enough blood to meet the body’s needs. It is a progressive disease that becomes more severe over time and can be caused by a variety of factors, including heart attack, cardiomyopathy and heart valve disease. There are various methods to cure this disease, which has many complications and risks. The advancement of knowledge and technology has proposed new methods for many diseases. One of the promising new treatments for heart failure is tissue engineering. Tissue engineering is a field of research that aims to create living tissues and organs to replace damaged or diseased tissue. The goal of tissue engineering in heart failure is to improve cardiac function and reduce the need for heart transplantation. This can be done using the three important principles of cells, biomaterials and signals to improve function or replace heart tissue. The techniques for using cells and biomaterials such as electrospinning, hydrogel synthesis, decellularization, etc. are diverse. Treating heart failure through tissue engineering is still under development and research, but it is hoped that there will be no transplants or invasive surgeries in the near future. In this study, based on the most important research in recent years, we will examine the power of tissue engineering in the treatment of heart failure.

show abstract

Cardiovascular diseases in people with diabetes mellitus in Spain according to the Primary Care Clinical Database (BDCAP) in 2017

Cited by 3 publications

References 40 publications

Análisis Real World Data de algunas repercusiones de la pandemia de COVID-19 sobre el control metabólico de las personas con DM2

Análisis Real World Data de algunas repercusiones de la pandemia de COVID-19 sobre el control metabólico de las personas con DM2

Green liquid chromatographic method for simultaneous determination of metformin, linagliptin and rivaroxaban: Tablet manufacturing and application to in-vitro dissolution studies

Cardiac tissue engineering: an emerging approach to the treatment of heart failure

Contact Info

Product

Resources

About